Table 2

Standardised incidence ratios (SIR) for subsequent cancers after diagnosis of colorectal cancer in women, by age at diagnosis of colorectal cancer

	Colorectal cancer diagnosed at age <60 years				Colorectal cancer diagnosed at age 60+ years
Site	n	SIR	Lower 95% CI	Upper 95% CI	n	SIR	Lower 95% CI	Upper 95% CI
p<0.05, *p<0.01.
Tongue	2	0.94	0.12	3.41	6	1.43	0.52	3.10
Mouth	1	0.41	0.01	2.28	2	0.42	0.05	1.50
Oropharynx	1	1.01	0.03	5.63	0
Oesophagus	12	0.94	0.49	1.65	30	0.81	0.55	1.16
Stomach	19	0.76	0.45	1.18	46	0.55**	0.40	0.73
Small intestine	3	2.33	0.48	6.80	8	2.86*	1.23	5.63
Colon	78	1.28*	1.02	1.60	99	0.60**	0.49	0.73
Rectum	33	1.04	0.72	1.47	38	0.49**	0.35	0.67
Liver	2	0.64	0.08	2.32	4	0.56	0.15	1.42
Gall bladder	2	0.41	0.05	1.50	5	0.38*	0.12	0.89
Pancreas	15	0.66	0.37	1.09	34	0.54**	0.38	0.76
Larynx	3	1.06	0.22	3.09	1	0.23	0.01	1.29
Bronchus	106	1.14	0.93	1.37	182	1.00	0.86	1.16
Connective tissue	5	2.27	0.74	5.30	5	1.23	0.40	2.87
Skin melanoma	14	1.19	0.65	2.00	14	0.89	0.49	1.50
Breast	229	1.10	0.96	1.26	284	0.96	0.85	1.08
Cervix uteri	35	1.61*	1.12	2.24	34	1.42	0.99	1.99
Corpus uteri	57	1.56**	1.18	2.02	49	0.98	0.72	1.29
Ovary	110	2.56**	2.11	3.09	97	1.59**	1.29	1.94
Other female genital	11	1.65	0.82	2.96	20	1.12	0.68	1.72
Bladder	19	0.91	0.55	1.42	54	0.98	0.73	1.27
Kidney	11	1.10	0.55	1.97	25	1.29	0.84	1.90
Eye	4	2.19	0.60	5.60	3	1.19	0.25	3.46
Brain, nervous system	6	0.55	0.20	1.19	7	0.61	0.25	1.26
Thyroid	8	2.24	0.97	4.42	10	1.56	0.75	2.86
NHL	15	0.76	0.43	1.26	28	0.71	0.47	1.03
Multiple myeloma	7	0.73	0.29	1.50	14	0.62	0.34	1.04
Lymphoid leukaemia	3	0.52	0.11	1.53	16	1.01	0.58	1.64
Myeloid leukaemia	6	0.87	0.32	1.90	19	1.15	0.69	1.80
Other leukaemia	0				4	1.20	0.33	3.07
Total	827	1.19**	1.11	1.28	1147	0.87**	0.82	0.92
Total excl colorectal	716	1.19**	1.11	1.28	1010	0.93*	0.88	0.99